“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: P.30 The relation between the abnormality of the P53 gene and the epidemiological and biological parameters

€2.42

SKU: product-article-15540 Category: General

Description

Description

P.30 The relation between the abnormality of the P53 gene and the epidemiological and biological parameters

Top

Article: P.30 The relation between the abnormality of the P53 gene and the epidemiological and biological parameters

Description

Related products

Article: Calendar of events

Article: Highlights in respiratory oncology

Article: INTRODUCTION

Article: Highlights in melanoma